Kura Oncology, Inc.
Symbol: KURA
NASDAQ
20.59
USDDzisiejsza cena rynkowa
-10.6467
Wskaźnik P/E
-0.2997
Wskaźnik PEG
1.57B
Kapitalizacja MRK
- 0.00%
Rentowność DIV
Kura Oncology, Inc. (KURA) Sprawozdania finansowe
Bilans
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 1880.65 | 424 | 438 | 518 | ||||||||||||||||
balance-sheet.row.short-term-investments | 1723.96 | 386.6 | 386.2 | 427.3 | ||||||||||||||||
balance-sheet.row.net-receivables | 2.8 | 2.8 | 0 | 0 | ||||||||||||||||
balance-sheet.row.inventory | 0 | 0 | 0 | 0 | ||||||||||||||||
balance-sheet.row.other-current-assets | 32.43 | 5.7 | 8.4 | 4.3 | ||||||||||||||||
balance-sheet.row.total-current-assets | 1907.21 | 432.5 | 446.4 | 522.3 | ||||||||||||||||
balance-sheet.row.property-plant-equipment-net | 31.78 | 8.9 | 6.4 | 8.2 | ||||||||||||||||
balance-sheet.row.goodwill | 0 | 0 | 0 | 0 | ||||||||||||||||
balance-sheet.row.intangible-assets | 0 | 0 | 0 | 0 | ||||||||||||||||
balance-sheet.row.goodwill-and-intangible-assets | 0 | 0 | 0 | 0 | ||||||||||||||||
balance-sheet.row.long-term-investments | 0.61 | 0.2 | 0.2 | 0.2 | ||||||||||||||||
balance-sheet.row.tax-assets | 0 | 0 | 0 | 0 | ||||||||||||||||
balance-sheet.row.other-non-current-assets | 23.08 | 7.4 | 3.3 | 3.3 | ||||||||||||||||
balance-sheet.row.total-non-current-assets | 55.47 | 16.5 | 9.9 | 11.8 | ||||||||||||||||
balance-sheet.row.other-assets | 8.67 | 0 | 0 | 0 | ||||||||||||||||
balance-sheet.row.total-assets | 1971.35 | 448.9 | 456.3 | 534.1 | ||||||||||||||||
balance-sheet.row.account-payables | 6.4 | 2.3 | 1.5 | 3.2 | ||||||||||||||||
balance-sheet.row.short-term-debt | 6.9 | 1.5 | 2.3 | 2.3 | ||||||||||||||||
balance-sheet.row.tax-payables | 0 | 0 | 0 | 0 | ||||||||||||||||
balance-sheet.row.long-term-debt-total | 51.38 | 9.3 | 11.7 | 4.6 | ||||||||||||||||
Deferred Revenue Non Current | 0 | 0 | 0 | 0 | ||||||||||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 0 | - | - | - | ||||||||||||||||
balance-sheet.row.other-current-liab | 109.76 | 31.5 | 20.2 | 17 | ||||||||||||||||
balance-sheet.row.total-non-current-liabilities | 60.43 | 16.4 | 12 | 5 | ||||||||||||||||
balance-sheet.row.other-liabilities | -23.9 | 0 | 0 | 0 | ||||||||||||||||
balance-sheet.row.capital-lease-obligations | 25.89 | 6.4 | 4.9 | 6.9 | ||||||||||||||||
balance-sheet.row.total-liab | 155.48 | 51.7 | 36 | 27.4 | ||||||||||||||||
balance-sheet.row.preferred-stock | 0 | 0 | 0 | 0 | ||||||||||||||||
balance-sheet.row.common-stock | 0.03 | 0 | 0 | 0 | ||||||||||||||||
balance-sheet.row.retained-earnings | -2811.11 | -721.4 | -568.8 | -433 | ||||||||||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | -10.84 | -1.3 | -8 | -1.8 | ||||||||||||||||
balance-sheet.row.other-total-stockholders-equity | 3514.16 | 1120 | 8 | 1.8 | ||||||||||||||||
balance-sheet.row.total-stockholders-equity | 692.24 | 397.3 | -568.8 | -433 | ||||||||||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 871.62 | 448.9 | -532.8 | -405.5 | ||||||||||||||||
balance-sheet.row.minority-interest | 0 | 0 | 0 | 0 | ||||||||||||||||
balance-sheet.row.total-equity | 692.24 | 397.3 | -568.8 | -433 | ||||||||||||||||
balance-sheet.row.total-liabilities-and-total-equity | 871.62 | - | - | - | ||||||||||||||||
Total Investments | 1724.16 | 386.8 | 386.2 | 427.3 | ||||||||||||||||
balance-sheet.row.total-debt | 64.64 | 17.2 | 14 | 6.9 | ||||||||||||||||
balance-sheet.row.net-debt | -92.05 | -20.1 | -37.8 | -83.8 |
Rachunek przepływów pieniężnych
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | -168.09 | -152.6 | -135.8 | -130.5 | ||||||||||||||||
cash-flows.row.depreciation-and-amortization | -2.39 | 0.8 | 0.8 | 0.6 | ||||||||||||||||
cash-flows.row.deferred-income-tax | 0 | -19.5 | 0 | 4.6 | ||||||||||||||||
cash-flows.row.stock-based-compensation | 21.24 | 28.1 | 26.3 | 23.6 | ||||||||||||||||
cash-flows.row.change-in-working-capital | 15.09 | 7.8 | -3 | -3.2 | ||||||||||||||||
cash-flows.row.account-receivables | 0 | 0 | 0 | 0 | ||||||||||||||||
cash-flows.row.inventory | 0 | 0 | 0 | 0 | ||||||||||||||||
cash-flows.row.account-payables | 12.56 | 10.3 | -0.8 | -2.5 | ||||||||||||||||
cash-flows.row.other-working-capital | -0.6 | -2.5 | -2.2 | -0.7 | ||||||||||||||||
cash-flows.row.other-non-cash-items | -7.37 | 10.5 | 1.7 | 0.4 | ||||||||||||||||
cash-flows.row.net-cash-provided-by-operating-activities | -137.8 | 0 | 0 | 0 | ||||||||||||||||
cash-flows.row.investments-in-property-plant-an-equipment | -0.22 | -0.2 | -0.6 | -1.1 | ||||||||||||||||
cash-flows.row.acquisitions-net | 0.01 | -15.6 | 0 | 0.1 | ||||||||||||||||
cash-flows.row.purchases-of-investments | -531.05 | -409.8 | -270.7 | -445.7 | ||||||||||||||||
cash-flows.row.sales-maturities-of-investments | 440.36 | 425.5 | 303.9 | 320 | ||||||||||||||||
cash-flows.row.other-investing-activites | -0.01 | 15.6 | 0 | -0.1 | ||||||||||||||||
cash-flows.row.net-cash-used-for-investing-activites | -90.91 | 15.6 | 32.6 | -126.8 | ||||||||||||||||
cash-flows.row.debt-repayment | 0 | 0 | -9.4 | -7.3 | ||||||||||||||||
cash-flows.row.common-stock-issued | 240.6 | 94.8 | 24.7 | 4.4 | ||||||||||||||||
cash-flows.row.common-stock-repurchased | 0 | 0 | 0 | 0 | ||||||||||||||||
cash-flows.row.dividends-paid | 0 | 0 | 0 | 0 | ||||||||||||||||
cash-flows.row.other-financing-activites | 97.43 | 94.8 | 23.3 | -0.6 | ||||||||||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | 243.15 | 94.8 | 38.6 | -3.4 | ||||||||||||||||
cash-flows.row.effect-of-forex-changes-on-cash | 0 | 0 | 0 | 0 | ||||||||||||||||
cash-flows.row.net-change-in-cash | 14.24 | -14.5 | -38.9 | -234.8 | ||||||||||||||||
cash-flows.row.cash-at-end-of-period | 156.9 | 37.3 | 52 | 90.9 | ||||||||||||||||
cash-flows.row.cash-at-beginning-of-period | 142.66 | 51.8 | 90.9 | 325.7 | ||||||||||||||||
cash-flows.row.operating-cash-flow | -137.8 | -124.8 | -110.1 | -104.6 | ||||||||||||||||
cash-flows.row.capital-expenditure | -0.22 | -0.2 | -0.6 | -1.1 | ||||||||||||||||
cash-flows.row.free-cash-flow | -138.01 | -125 | -110.7 | -105.7 |
Wiersz rachunku zysków i strat
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 1.27 | 0 | 0 | 0 | ||||||||||||||||
income-statement-row.row.cost-of-revenue | 0.64 | 0.8 | 0.8 | 0.6 | ||||||||||||||||
income-statement-row.row.gross-profit | 0.63 | -0.8 | -0.8 | -0.6 | ||||||||||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | ||||||||||||||||
income-statement-row.row.research-development | 126.31 | - | - | - | ||||||||||||||||
income-statement-row.row.selling-general-administrative | 57.38 | - | - | - | ||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | -0.21 | - | - | - | ||||||||||||||||
income-statement-row.row.other-expenses | -2.5 | 0 | 4 | 0.8 | ||||||||||||||||
income-statement-row.row.operating-expenses | 183.48 | 165 | 139.9 | 131.3 | ||||||||||||||||
income-statement-row.row.cost-and-expenses | 183.69 | 165.8 | 139.9 | 131.3 | ||||||||||||||||
income-statement-row.row.interest-income | 11.86 | 14.7 | 4.3 | 1.2 | ||||||||||||||||
income-statement-row.row.interest-expense | 0.01 | 1.5 | 0.2 | 0.4 | ||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | -0.21 | - | - | - | ||||||||||||||||
income-statement-row.row.total-other-income-expensenet | 10.68 | 13.2 | 4.8 | 1.4 | ||||||||||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | ||||||||||||||||
income-statement-row.row.other-operating-expenses | -2.5 | 0 | 4 | 0.8 | ||||||||||||||||
income-statement-row.row.total-operating-expenses | 10.68 | 13.2 | 4.8 | 1.4 | ||||||||||||||||
income-statement-row.row.interest-expense | 0.01 | 1.5 | 0.2 | 0.4 | ||||||||||||||||
income-statement-row.row.depreciation-and-amortization | 0.64 | 0.8 | 0.8 | 0.6 | ||||||||||||||||
income-statement-row.row.ebitda-caps | -174.06 | - | - | - | ||||||||||||||||
income-statement-row.row.operating-income | -174.89 | -165.8 | -140.6 | -131.8 | ||||||||||||||||
income-statement-row.row.income-before-tax | -168.09 | -152.6 | -135.8 | -130.5 | ||||||||||||||||
income-statement-row.row.income-tax-expense | 3.07 | 0 | 0.2 | -0.6 | ||||||||||||||||
income-statement-row.row.net-income | -168.09 | -152.6 | -136.1 | -129.9 |
Często zadawane pytania
Ile wynosi Kura Oncology, Inc. (KURA) aktywów ogółem?
Kura Oncology, Inc. (KURA) całkowite aktywa to 448935000.000.
Jaki jest roczny przychód przedsiębiorstwa?
Roczny przychód to 1270000.000.
Jaka jest marża zysku firmy?
Marża zysku firmy to 0.331.
Czym są wolne przepływy pieniężne firmy?
Wolne przepływy pieniężne to -1.616.
Jaka jest marża zysku netto przedsiębiorstwa?
Marża zysku netto to -117.767.
Jaki jest całkowity przychód firmy?
Całkowity przychód to -127.669.
Co to jest Kura Oncology, Inc. (KURA) zysk netto (dochód netto)?
Zysk netto (dochód netto) wynosi -152631000.000.
Jakie jest całkowite zadłużenie firmy?
Całkowite zadłużenie to 17200000.000.
Ile wynoszą koszty operacyjne?
Wydatki operacyjne to 164955000.000.
Jaka jest wartość gotówki firmy?
Środki pieniężne przedsiębiorstwa to 41506000.000.